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The nerves that innervate white adipose tissues include numerous peripheral nerve 1 0 6 subtypes, such as sensory, parasympathetic and sympathetic nerves [12] [13] [14] . Although the number 1 0 7
of studies assessing adipose innervation are increasing, further demonstrating the importance 1 0 8 of brain-adipose communication [15] [16] [17] , it is still unclear which neurotransmitters and 1 0 9
neuropeptides, aside from the well-studied norepinephrine, are synaptically released in adipose 1 1 0
tissue and onto which receptor-expressing cell types. A better understanding of how the 1 1 1 peripheral nerves in adipose tissue are regulated is important for the field, including differences 1 1 2
in nerve plasticity between innervation of BAT and WAT, as well as sex differences in 1 1 3 innervation density.
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In other tissues, and in many organisms, peripheral nerves are appreciated as plastic 1 1 5
(ie: able to undergo remodeling of neurites and synapses in response to stimuli), or neuropathic 1 1 6
(dying-back in pathophysiological conditions). For example, with distal peripheral neuropathy 1 1 7
nerves in the skin of distal extremities can die back through an unclear process, resulting in 1 1 8
pain, loss of sensation, and severe discomfort. The process begins in the skin and moves 1 1 9
inward. Neuropathy can be caused by aging, certain drugs (such as antibiotics and 1 2 0 chemotherapy agents), or diabetes [18] [19] [20] . Diabetic neuropathy is especially prominent, affecting 1 2 1 over 50% of diabetic individuals, and often leads to limb amputation 21, 22 . Aging is associated 1 2 2 with a loss of metabolic regulation and an increased propensity for diabetes [23] [24] [25] , and is 1 2 3
independently associated with peripheral neuropathy 26 . The debilitating aspects of peripheral 1 2 4 neuropathy are largely due to the inability to prevent or treat these conditions, and the inability 1 2 5
to halt and reverse the neurodegeneration. Standard clinical approaches include pain 1 2 6 management or glucose regulation (with diabetic neuropathy), but no therapies are currently 1 2 7
approved to mitigate nerve death or to stimulate peripheral nerve re-growth or re-myelination. It 1 2 8
is important to understand whether or not neuropathy can extend below the skin into underlying 1 2 9
adipose tissue, which may exacerbate metabolic disease.
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Given the close association between situations of metabolic dysregulation (aging, 1 3 1 obesity, diabetes) and peripheral neuropathy, and the clear importance of adipose tissue 1 3 2
innervation for metabolic homeostasis, we sought to determine if adipose tissue nerves also 1 3 3
undergo neuropathy with these conditions. To do this, we assessed human adipose tissue 1 3 4
samples across a range of ages and body mass indices (BMIs), and also utilized mouse models 1 3 5
of aging and obesity/diabetes. We hypothesized that age and obesity/diabetes would be 1 3 6
positively correlated with a loss of proper innervation of adipose tissues. We also sought to 1 3 7
determine which interventions could stimulate re-innervation of adipose tissue in situations of 1 3 8
adipose neuropathy, through a beneficial and physiological process of nerve plasticity. In order to determine changes to sensory nerves innervating WAT, we assessed gene 3 7 8 expression in the T13-L1 dorsal root ganglion (DRG), which is known to innervate inguinal 3 7 9 scWAT 35, 36 (Fig. 3f) In order to gain a comprehensive understanding of the neural network within inguinal 3 9 0
scWAT we explored various immunostaining methods and microscopy techniques.
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Immunostaining of standard paraffin embedded 7uM tissue sections (Suppl. Fig. S6a ) provides 3 9 2 incomplete information, since nerve fibers are bisected and appear only as puncta. ScaleView-3 9 3
A2 tissue clearing method allowed for visualization of intact inguinal scWAT depots of a TH-3 9 4
reporter mouse (Suppl. Fig. S6b ) and revealed region specific increases of sympathetic 3 9 5 activation in 7 day cold exposed mice, when compared to animals that were cold exposed and 3 9 6
then rewarmed for 4 weeks. Confocal microscopy with depth coding of sucrose-cleared inguinal 3 9 7
scWAT revealed that nerves penetrate the inguinal scWAT depot and are not merely running 3 9 8
along the surface (Suppl. Fig. S6c ). Although tissue-clearing methods allowed for an intact 3 9 9
depot without flattening and distortion of tissue boundaries, tissues (especially from 80g BTBR 4 0 0 MUT mice) were too large for lightsheet microscopy, and too thick for standard confocal.
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To overcome these limitations, a method was developed which allowed for whole depot 
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We also compared the use of antibodies to nerve reporter mouse strains In addition to exercise as a means to promote adipose tissue neural plasticity, we found 4 2 5
that cold stimulation also increased adipose tissue innervation, as protein levels of PGP9.5 went 4 2 6 up in scWAT after 3 days of cold exposure compared to tissues from mice housed at room 4 2 7 temperature or thermoneutrality (Fig. 4a) . To examine the adipose nerve network under this 4 2 8 innervation promoting condition, adult mice maintained at room temperature (RT) were 4 2 9 compared to littermates that were either cold exposed for 10 days or cold exposed for 10 days 
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After cold exposure, a distinct change in the neural arborization pattern was observed 4 3 8 (Fig. 4b, middle tissues. This can also be seen when looking at the 2D representations in Fig. 4b , where the 4 4 6
anterior and posterior portions display differences in innervation status after cold.
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Of note, average innervation density per inguinal scWAT depot totaled up to 25 meters 4 4 8
per tissue depot, underscoring the great density of nerve fibers contained in WAT depots.
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Furthermore, the inguinal scWAT depot can be considered to have 3 distinct anatomical 
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In separate experiments, we mimicked cold exposure by delivering the beta-3 adrenergic 4 6 0 agonist CL316,243 ('CL') to wild type mice, and measured secretion of the neurotrophic factor 4 6 1 BDNF from scWAT tissue explants. This approach revealed a significant increase in BDNF 4 6 2 secretion after 10-14 days of CL treatments (Fig. 4d) of TH or PSD95 following AAV-BDNF treatment (Suppl. Fig. 8a -b) for this dose and duration.
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Taken together, these data suggest a role for BDNF in promoting total innervation on inguinal 4 7 4
scWAT. revealed that at least some of these vascular-associated nerves are myelinated (Suppl. or diet and exercise interventions. In this study, we have found a promising novel treatment by 5 2 5
locally delivering scWAT with AAV-BDNF, which appeared to succeed in re-innervating the 5 2 6
tissues of diabetic mice.
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Interestingly, while diet and exercise are often prescribed in concert, despite exercise 5 2 8
not being a very effective means to reduce appetite, the myriad health benefits of exercise may 5 2 9
help to bolster additional weight loss strategies. This may be in part by mediating increased 5 3 0
peripheral nerve plasticity, including in adipose depots, as we have demonstrated here.
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Furthermore, we have also demonstrated that cold exposure similarly boosts peripheral nerve 5 3 2 plasticity in adipose, and may also be a strategy to enhance diet and exercise-based weight 5 3 3 loss interventions.
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We have demonstrated that both mouse and human scWAT undergo neuropathy with 5 3 5
aging and obesity, and these data provide evidence that peripheral neuropathy is not restricted clinical details. Western blot data were normalized to β-actin, band intensity were quantified in 6 5 7
Image J, and analyzed by two-tailed Student's T-Test. Error bars are SEMs, *p < 0.05, **p < 6 5 8
0.01, ***p < 0.001, ****p < 0.0001.
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Figure 2. Aging is associated with adipose tissue neuropathy. In young (10-12 weeks old) representative of N=4 mice analyzed per group. Error bars are SEMs, *p < 0.05, **p < 0.01, ***p 6 7 7
< 0.001, ****p < 0.0001. (red/orange); images were captured at 10x (e). Images are representative of N=5 mice analyzed 6 9 7
per group. Young (12-15 weeks old) male C57BL/6J mice were placed in running-wheel cages 6 9 8
for 7 days with continuous access to a running wheel (run), control (sed) animals were placed in 6 9 9
cages with a locked running wheel. Gene expression of neuropeptides in the T13-L1 DRGs was , e t a l .
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